Michael Reed, DPM
Foot & Ankle Surgery · Missoula, MTNPI 1902053358
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.4%), food and beverage and other — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Trilliant Surgical LLC. at 40.8% of the total. Reporting peaked in 2023 at $2,140 and has fallen 79.5% since, to $440 in 2025.
Across 40 payments — averaging $81.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Trilliant Surgical LLC.$1K
- Medshape, Inc.$792
- Integra Lifesciences Corporation$343
- Stryker$262
- Organogenesis Inc.$157
- DJO, LLC$112
- plus $273 from 8 others
What the payments were for
- Travel & lodging$1,84756%
- Food & beverage$1,06132%
- Education$1123%
- Other$2558%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Trilliant Surgical LLC. | 5 | $1,337 |
| Medshape, Inc. | 4 | $792 |
| Integra Lifesciences Corporation | 4 | $343 |
| Stryker | 9 | $262 |
| Organogenesis Inc. | 6 | $157 |
| DJO, LLC | 2 | $112 |
| Medtronic(2 entities) | 2 | $107 |
| Ortho Solutions Inc | 1 | $37 |
| Sioux Surgical Inc | 2 | $35 |
| Anika Therapeutics, Inc. | 1 | $26 |
| Medline Industries LP | 1 | $23 |
| Averitas Pharma Inc. | 1 | $17 |
| Smith+Nephew | 1 | $14 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,275 in reported general payments places this provider in the 55th percentile of 34 foot & ankle surgery providers in Montana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 34 | $865 |
| Fluconazole | 45 | $492 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $306 |
| Gabapentin | 24 | $209 |
| Doxycycline Hyclate | 27 | $177 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $163 |
| Mupirocin | 11 | $103 |
| Methylprednisolone | 16 | $87 |
| Oxycodone Hcl | 17 | $70 |
| Triamcinolone Acetonide | 11 | $53 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Missoula
- Brian SchenavarMissoula$34K
- Brent RosterMissoula$24K
- Nathan ThomasMissoula$724
- Karl MangoldMissoula$473
- Kevin WhittonMissoula$327
- Dallin GreeneGlendive$187K
- Ronald RayGreat Falls$166K
- Andrew RiceLivingston$130K
- Zachary LubekBillings$18K
- Jennifer Gravos-BauerSidney$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.